The pharmaceutical industry is now waging a broad-based assault on Biden's Inflation Reduction Act, including the measure to negotiate Medicare drug prices — just as the negotiations are about to begin. Via the New York Times: On Tuesday, Johnson & Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a halt to the drug pricing program.

Sections:  politics   
BING NEWS:
  • Medicare’s new drug price cap kicks in Jan. 1
    A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual out-of-pocket spending on prescription drugs to $2,000 for Medicare ...
    12/31/2024 - 4:30 am | View Link
  • How Big Pharma Is Wrecking the Inflation Reduction Act
    The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden administration’s key achievement.
    12/25/2024 - 10:03 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Politics News